Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Chelle

Showing results (1-10 of 32) with videos related to

Pageof 4
Sort By:
Journal of Thrombosis and Haemostasis : JTH|June 26, 2022
A personalized limited sampling approach to better estimate terminal half-life of FVIII concentratesPierre Chelle, Alfonso Iorio, Andrea N Edginton
Thrombosis Research|November 6, 2019
A comparison of methods for prediction of pharmacokinetics across factor concentrate switching in hemophilia patientsJacky K Yu, Alfonso Iorio, Pierre Chelle, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 2, 2021
Pharmacokinetic implications of dosing emicizumab based on vial size: A simulation studyJacky K Yu, Alfonso Iorio, Pierre Chelle, et al.
Research and Practice in Thrombosis and Haemostasis|February 13, 2026
Country-level prediction of blood type distribution in hemophilia A in support of factor VIII consumptionPierre Chelle, Sam Hirniak, Dagmar Hajducek, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 7, 2025
Exploring the Impact of Laboratory Reagents on Pharmacokinetic ProfilingPierre Chelle, Dagmar Hajducek, Emma Iserman, et al.
Journal of Pharmacokinetics and Pharmacodynamics|April 13, 2021
Use of population PK/PD approach to model the thrombin generation assay: assessment in haemophilia A plasma samples spiked by a TFPI antibodyRaphaël Crépin, Claire Morin, Aurélie Montmartin, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 10, 2025
A Global Cross-Sectional Database Study of Low Dose FVIII SHL Prophylaxis in Haemophilia ADagmar M Hajducek, Oceana Sinkovic, Pierre Chelle, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 13, 2024
Estimated prophylactic dose required to achieve 3% trough as a function of age and concentrate class in multi-country severe WAPPS-Hemo haemophilia patientsDagmar M Hajducek, Pierre Chelle, Alfonso Iorio, et al.
Bulletin of Mathematical Biology|June 28, 2018
Evaluation and Calibration of In Silico Models of Thrombin Generation Using Experimental Data from Healthy and Haemophilic SubjectsPierre Chelle, Claire Morin, Aurélie Montmartin, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 9, 2021
Comparison of single subject and population-based pharmacokinetics for optimizing prophylaxis with simoctocog alfa in patients with haemophilia AJan Astermark, Anna Olsson, Pierre Chelle, et al.
Pageof 4

Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
Journal of Thrombosis and Haemostasis : JTH|June 26, 2022
A personalized limited sampling approach to better estimate terminal half-life of FVIII concentratesPierre Chelle, Alfonso Iorio, Andrea N Edginton
Thrombosis Research|November 6, 2019
A comparison of methods for prediction of pharmacokinetics across factor concentrate switching in hemophilia patientsJacky K Yu, Alfonso Iorio, Pierre Chelle, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 2, 2021
Pharmacokinetic implications of dosing emicizumab based on vial size: A simulation studyJacky K Yu, Alfonso Iorio, Pierre Chelle, et al.
Research and Practice in Thrombosis and Haemostasis|February 13, 2026
Country-level prediction of blood type distribution in hemophilia A in support of factor VIII consumptionPierre Chelle, Sam Hirniak, Dagmar Hajducek, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 7, 2025
Exploring the Impact of Laboratory Reagents on Pharmacokinetic ProfilingPierre Chelle, Dagmar Hajducek, Emma Iserman, et al.
Journal of Pharmacokinetics and Pharmacodynamics|April 13, 2021
Use of population PK/PD approach to model the thrombin generation assay: assessment in haemophilia A plasma samples spiked by a TFPI antibodyRaphaël Crépin, Claire Morin, Aurélie Montmartin, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 10, 2025
A Global Cross-Sectional Database Study of Low Dose FVIII SHL Prophylaxis in Haemophilia ADagmar M Hajducek, Oceana Sinkovic, Pierre Chelle, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 13, 2024
Estimated prophylactic dose required to achieve 3% trough as a function of age and concentrate class in multi-country severe WAPPS-Hemo haemophilia patientsDagmar M Hajducek, Pierre Chelle, Alfonso Iorio, et al.
Bulletin of Mathematical Biology|June 28, 2018
Evaluation and Calibration of In Silico Models of Thrombin Generation Using Experimental Data from Healthy and Haemophilic SubjectsPierre Chelle, Claire Morin, Aurélie Montmartin, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 9, 2021
Comparison of single subject and population-based pharmacokinetics for optimizing prophylaxis with simoctocog alfa in patients with haemophilia AJan Astermark, Anna Olsson, Pierre Chelle, et al.
Pageof 4